Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuaki Sagara

Showing results (11-20 of 131) with videos related to

Pageof 14
Sort By:
Cancer|February 22, 2017
Breast cancer prevention strategies in lobular carcinoma in situ: A decision analysisStephanie M Wong, Natasha K Stout, Rinaa S Punglia, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 14, 2006
[Markedly effective regimen using bi-weekly trastuzumab and paclitaxel in an advanced breast cancer with multiple liver metastases]Yoshiaki Rai, Tetsuya Takahama, Yoshiaki Sagara, et al.
Breast Cancer (Tokyo, Japan)|August 5, 2011
Study on the state of implementation of HER2 testing and positive ratios in patients with breast cancer in the Kyushu-Okinawa region of JapanYasuaki Sagara, Yoshihiko Kamada, Yutaka Yamamoto, et al.
Molecular and Clinical Oncology|March 21, 2014
Evaluation of PTEN loss and PIK3CA mutations and their correlation with efficacy of trastuzumab treatment in HER2-positive metastatic breast cancer: A retrospective study (KBC-SG 1001)Reiki Nishimura, Nobuyuki Arima, Satoshi Toyoshima, et al.
Diagnostic Pathology|April 19, 2011
Maspin expression is frequent and correlates with basal markers in triple-negative breast cancerYoshihisa Umekita, Yasuyo Ohi, Masakazu Souda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 19, 2009
[Comparison of the pharmacokinetics and safety of a paclitaxel injection NK and Taxol injection in breast cancer patients]Yoshiaki Sagara, Yoshiaki Rai, Yoshiatsu Sagara, et al.
Histopathology|July 24, 2018
Maspin mRNA expression in sentinel lymph nodes predicts non-SLN metastasis in breast cancer patients with SLN metastasisYoshihisa Umekita, Yasuyo Ohi, Orie Iwaya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2016
Reply to K. Lin et alYasuaki Sagara, Rachel A Freedman, Melissa Anne Mallory, et al.
JAMA Surgery|June 4, 2015
Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ: A Population-Based Cohort StudyYasuaki Sagara, Melissa Anne Mallory, Stephanie Wong, et al.
Breast Cancer Research and Treatment|August 13, 2019
Diffuse distribution of tumor-infiltrating lymphocytes is a marker for better prognosis and chemotherapeutic effect in triple-negative breast cancerAkira I Hida, Takahiro Watanabe, Yasuaki Sagara, et al.
Pageof 14

Showing results (11-20 of 131) with videos related to

Sort By:
Pageof 14
Cancer|February 22, 2017
Breast cancer prevention strategies in lobular carcinoma in situ: A decision analysisStephanie M Wong, Natasha K Stout, Rinaa S Punglia, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 14, 2006
[Markedly effective regimen using bi-weekly trastuzumab and paclitaxel in an advanced breast cancer with multiple liver metastases]Yoshiaki Rai, Tetsuya Takahama, Yoshiaki Sagara, et al.
Breast Cancer (Tokyo, Japan)|August 5, 2011
Study on the state of implementation of HER2 testing and positive ratios in patients with breast cancer in the Kyushu-Okinawa region of JapanYasuaki Sagara, Yoshihiko Kamada, Yutaka Yamamoto, et al.
Molecular and Clinical Oncology|March 21, 2014
Evaluation of PTEN loss and PIK3CA mutations and their correlation with efficacy of trastuzumab treatment in HER2-positive metastatic breast cancer: A retrospective study (KBC-SG 1001)Reiki Nishimura, Nobuyuki Arima, Satoshi Toyoshima, et al.
Diagnostic Pathology|April 19, 2011
Maspin expression is frequent and correlates with basal markers in triple-negative breast cancerYoshihisa Umekita, Yasuyo Ohi, Masakazu Souda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 19, 2009
[Comparison of the pharmacokinetics and safety of a paclitaxel injection NK and Taxol injection in breast cancer patients]Yoshiaki Sagara, Yoshiaki Rai, Yoshiatsu Sagara, et al.
Histopathology|July 24, 2018
Maspin mRNA expression in sentinel lymph nodes predicts non-SLN metastasis in breast cancer patients with SLN metastasisYoshihisa Umekita, Yasuyo Ohi, Orie Iwaya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2016
Reply to K. Lin et alYasuaki Sagara, Rachel A Freedman, Melissa Anne Mallory, et al.
JAMA Surgery|June 4, 2015
Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ: A Population-Based Cohort StudyYasuaki Sagara, Melissa Anne Mallory, Stephanie Wong, et al.
Breast Cancer Research and Treatment|August 13, 2019
Diffuse distribution of tumor-infiltrating lymphocytes is a marker for better prognosis and chemotherapeutic effect in triple-negative breast cancerAkira I Hida, Takahiro Watanabe, Yasuaki Sagara, et al.
Pageof 14